Chandra M. Panthi

T405, a New Penem, Exhibits In Vivo Efficacy against M. abscessus and Synergy with β-Lactams Imipenem and Cefditoren

G. Lamichhane, C. Townsend, E. Nuermberger, 2022, Antimicrobial agents and chemotherapy.

T405, a New Penem, Exhibits In Vivo Efficacy against M. abscessus and Synergy with β-Lactams Imipenem and Cefditoren

G. Lamichhane, C. Townsend, E. Nuermberger, 2022, Antimicrobial agents and chemotherapy.

Clofazimine as a comparator for preclinical efficacy evaluations of experimental therapeutics against pulmonary M. abscessus infection in mice.

G. Lamichhane, D. Sriram, Chandra M. Panthi, 2022, Tuberculosis.

Microbiological profile, preclinical pharmacokinetics and efficacy of CRS0393, a novel antimycobacterial agent targeting MmpL3.

G. Lamichhane, T. Jarvis, H. Zgurskaya, 2022, Tuberculosis.

Efficacy of Omadacycline-Containing Regimen in a Mouse Model of Pulmonary Mycobacteroides abscessus Disease

G. Lamichhane, Binayak Rimal, A. Serio, 2023, mSphere.

Efficacies of omadacycline + amikacin + imipenem and an all-oral regimen omadacycline + clofazimine + linezolid in a mouse model of M. abscessus lung disease

G. Lamichhane, Binayak Rimal, E. Ignatius, 2024, Msphere.

Efficacy of epetraborole against Mycobacteroides abscessus in a mouse model of lung infection

G. Lamichhane, Binayak Rimal, Chandra M. Panthi, 2024, Antimicrobial agents and chemotherapy.

Efficacies of three drug regimens containing omadacycline to treat Mycobacteroides abscessus disease.

G. Lamichhane, Binayak Rimal, E. Ignatius, 2024, Tuberculosis.